Teva Pharmaceutical Industries (TEVA) Tax Rate (2017 - 2026)

Teva Pharmaceutical Industries has disclosed Tax Rate across 10 years of filings, most recently posting 15.33% for Q1 2026.

• Quarterly Tax Rate fell 984.0% year-over-year to 15.33% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 13.69% (up 13947.0% YoY) and the FY2025 annual result came in at 14.72%, up 3793.0% from the prior year.
• Tax Rate grew to 15.33% in Q1 2026, from 487.5% in the prior quarter.
• Over five years, Tax Rate peaked at 76.4% in Q2 2022 and troughed at 487.5% in Q4 2025.
• A 5-year average of 36.94% and a median of 0.21% in 2022 frame the typical range for Tax Rate.
• Biggest YoY gain for Tax Rate was 21767 bps in 2025; the steepest drop was 47616 bps in 2025.
• Tracing TEVA's Tax Rate over 5 years: stood at 12.57% in 2022, then surged by 164 bps to 8.09% in 2023, then sank by 240 bps to 11.34% in 2024, then slumped by 4200 bps to 487.5% in 2025, then soared by 103 bps to 15.33% in 2026.
• Business Quant data shows TEVA's Tax Rate at 15.33% in Q1 2026, 487.5% in Q4 2025, and 33.13% in Q3 2025.